The rare pediatric disease priority review voucher would be saved under pending House legislation, but advocates would have to fight to keep it alive again in 2024.
House Energy and Commerce Committee members on 9 September sent to the full chamber a bill that would continue the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?